Open AccessInfluence of Estrogen Plus Testosterone Supplementation on Breast Cancer
Author(s) -
Roberta B. Ness,
Jessica Albano,
Anne McTiernan,
Jane A. Cauley
Publication year - 2009
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2008.507
Subject(s) - breast cancer , medicine , hazard ratio , oncology , confidence interval , cancer , estrogen , testosterone (patch) , gynecology , methyltestosterone , proportional hazards model , hormone therapy
Concern that the use of exogenous testosterone may increase breast cancer risk coexists with rising use of this medication in the United States. We sought to examine the relationship between the use of estrogen plus testosterone (E + T) therapy (esterified estradiol plus methyltestosterone) and the occurrence of breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom